JOINDER AGREEMENTJoinder Agreement • September 11th, 2017 • PRA Health Sciences, Inc. • Services-commercial physical & biological research • New York
JOINDER AGREEMENT, dated as of September 6, 2017 (this “Agreement” or “Joinder Agreement”), by and among the New Term Loan Lenders (as defined below), the Borrower (as defined below), the Guarantors party hereto, and Wells Fargo Bank, National Association (“Wells Fargo”) as Administrative Agent and Collateral Agent.
ContractSecurity Agreement • September 11th, 2017 • PRA Health Sciences, Inc. • Services-commercial physical & biological research
SUPPLEMENT NO. 1 dated as of September 6, 2017 (this “Supplement”), to the Security Agreement dated as of December 6, 2016 (as amended, restated, supplemented or otherwise modified from time to time, the “Security Agreement”), among PRA Health Sciences, Inc., a Delaware corporation (“Holdings”), Pharmaceutical Research Associates, Inc., a Virginia corporation (the “Borrower”), each of the Subsidiaries listed on the signature pages thereto or that becomes a party thereto pursuant to Section 8.14 thereof (each such entity being a “Subsidiary Grantor” and, collectively, the “Subsidiary Grantors”; the Subsidiary Grantors, Holdings and the Borrower are referred to collectively as the “Grantors”), and Wells Fargo Bank, National Association, as collateral agent (in such capacity, the “Collateral Agent”) for the benefit of the Secured Parties.
ContractSupplement No. • September 11th, 2017 • PRA Health Sciences, Inc. • Services-commercial physical & biological research
SUPPLEMENT NO. 1 dated as of September 6, 2017 (this “Supplement”) to the Guarantee dated as of December 6, 2016, among each of the Guarantors listed on the signature pages thereto and any other entity that becomes a party thereto pursuant to Section 20 thereof (each such entity individually, a “Guarantor” and, collectively, the “Guarantors”), and Wells Fargo Bank, National Association, as Collateral Agent for the Secured Parties (the “Guarantee”).
